AzTrials
AzTrials

Acute Physical ExerciseSPEMONCT04680494

Effect of Acute Physical Exercise on Memory

A study testing moderate intensity physical exercise, high intensity physical exercise and rest in people with Acute Physical Exercise, run by University of Geneva, Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

An increasing amount of studies show the beneficial effect of regular exercise on cognitive and brain functions and especially in the memory domain. Yet little is known of what happens within an acute bout of exercise and whether it would also yield cognitive effects. Read more about this study

Who is it for?
Ages 18 to 38 years, men onlyHealthy volunteers can take part
Conditions the study is for
Acute Physical Exercise
What is being tested?
moderate intensity physical exercise, high intensity physical exercise and rest
Could I receive a placebo?
No, everyone receives an active treatment
How many people
25 participants
Where
No sites listed yet
Study dates
9 Oct 2015to 27 Jul 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 38 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Male
  • Right-handed,
  • Exercising regularly (at least twice per week).
  • VO2max comprised between 40ml/kg/min and 65ml/kg/min.

Who cannot join

  • Psychiatric and neurological history

About this study

An increasing amount of studies show the beneficial effect of regular exercise on cognitive and brain functions and especially in the memory domain. Yet little is known of what happens within an acute bout of exercise and whether it would also yield cognitive effects. The literature clearly shows that molecules such as brain derived neurotrophic factor (BDNF) and endocannabinoids (mainly anandamide, AEA) are heavily involved in neural plasticity mechanisms and increase when we exercise hinting at possible mechanisms underlying memory improvement after exercise.

This protocol assesses the effects of acute exercise on associative and motor sequence memory, their underlying neural activations (measured using fMRI) and blood biomarkers (BDNF and AEA). A related aim is to assess the effect of exercise intensity, therefore three exercising conditions (rest, moderate intensity and high intensity) were included. Finally, a 3-month delayed retest visit is also realized to assess effects of acute exercise on long-term memory consolidation.

Being tested
moderate intensity physical exercise, high intensity physical exercise, rest
Keywords
fMRI, BDNF, endocannabinoid, physical exercise
Medical subject headings
Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • moderate intensity physical exerciseOther

  • high intensity physical exerciseOther

  • restOther

Study groups in NCT04680494
Study groupRoleWhat they receive
RestExperimentalParticipants rest quietly for 30 minutes, sitting on a chair. They may read magazines not involving motion-related elements
Receives: Other: rest
Moderate intensity exerciseExperimentalParticipants cycle on a cycle ergometer during 30 minutes at 65% of their maximal cardiac frequency
Receives: Other: moderate intensity physical exercise
High intensity exerciseExperimentalParticipants cycle on a cycle ergometer during 15 minutes at 75% of their maximal cardiac frequency. This session also includes 3 minutes of warm-up and three minutes of cool down at 50% of their maximal cardiac frequency
Receives: Other: high intensity physical exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. cognitive measures - performance

    we measure performance during cognitive tasks. Performance is measured as percentage of correct trials, with higher percentages corresponding to better performance - measured in percentages.

    Measured: Till the end of the study for each participant, i.e.3 months (long time retest)

  2. cognitive measures - reaction times

    we measure reaction times during cognitive tasks. For reaction times, lower measures correspond to faster response times and therefore to better outcome - measured in milliseconds.

    Measured: Till the end of the study for each participant, i.e.3 months (long time retest)

  3. BDNF levels

    we measure BDNF levels before and after physical exercise and rest, measured in ng/mL of serum.

    Measured: up to 1 hour

  4. endocannabinoid levels

    we measure endocannabinoid levels before and after physical exercise and rest, measured in ng/mL of plasma.

    Measured: up to 1 hour

  5. brain activations

    we measure brain activations using fMRI during cognitive tasks

    Measured: up to 1 hour

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Dec 2020
  2. Study start9 Oct 2015
  3. Primary completion27 Jul 2016
  4. Study completion27 Jul 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Crossover
Model description
This is a within-subject study, all participants perform all conditions in cross-over randomized order.
Masking
None (open label)
Enrolment
25 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04680494
Sponsor's protocol ID
PB_2017-00360
Acronym
SPEMO
Status last verified
Dec 2020
First submitted
11 Dec 2020
Last updated
23 Dec 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Marin Bosch B, Bringard A, Logrieco MG, Lauer E, Imobersteg N, Thomas A, Ferretti G, Schwartz S, Igloi K. Effect of acute physical exercise on motor sequence memory. Sci Rep. 2020 Sep 18;10(1):15322. doi: 10.1038/s41598-020-72108-1.

    PubMed 32948800

Questions about this trial

What is this clinical trial studying?

A study testing moderate intensity physical exercise, high intensity physical exercise and rest in people with Acute Physical Exercise, run by University of Geneva, Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Dec 2020. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

cognitive measures - performance (time frame: Till the end of the study for each participant, i.e.3 months (long time retest)). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04680494, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Dec 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in